2 results
Approved WMORecruiting
Objectives: The following trial objectives for adult patients with plasma therapy-resistantAtypical Hemolytic-Uremic Syndrome (aHUS) are to:Primary:• Assess the effect of eculizumab to reduce thrombotic microangiopathy (TMA) asindicated by…
Approved WMORecruiting
The primary objective is to examine the impact of t-LLVS on electrophysiological properties of the atria and ventricles.